| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $371.4B | $371.4B | $364.5B | $302.1B | $276.1B | $64.4B | $65.4B | $63.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $67.0B | $89.0B | $96.2B | $-22.8B | $89.8B | $35.8B | $29.2B | $-25.4B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1222.2B | $1153.9B | $1070.0B | $948.5B | $958.8B | $873.7B | $817.7B | $707.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $502.5B | $502.2B | $499.2B | — | — | $422.4B | $389.2B | $355.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $717.4B | $649.4B | $561.3B | $472.4B | $506.2B | $443.2B | $424.8B | $348.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $46.0B | $30.6B | $49.2B | $37.2B | $39.4B | $39.8B | $38.7B | $37.4B |
| Investing Cash Flow | $-44.5B | $-10.3B | $-32.7B | $-87.6B | $29.4B | $-37.8B | $-5.6B | $-32.8B |
| Capital Expenditures | $20.9B | $19.0B | $19.4B | $15.5B | $13.3B | $13.0B | $16.0B | $14.5B |
| Financing Cash Flow | $2.2B | $-10.4B | $-14.4B | $-1.7B | $-28.5B | $-18.3B | $0.7B | $-5.8B |